The first public molecular recognition database, BindingDB supports research, education and practice in drug discovery, pharmacology and related fields.

BindingDB contains 3.2M data for 1.4M Compounds and 11.5K Targets. Of those, 1.6M data for 765K Compounds and 4.8K Targets were curated by BindingDB curators. BindingDB is a FAIRsharing resource.

If BindingDB was of value to your research, please take a moment to donate to this nonprofit project. Your donation will let us provide you with more data and improved service.

To help with training and testing AI and other models, BindingDB downloads and search results now provide the publication date and BindingDB curation date of each measurement.

26 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review

PMID
Cmpds
Data
Article Title
Organization
16
Inhibition of the Aldehyde Dehydrogenase 1/2 Family by Psoralen and Coumarin Derivatives.EBI
Indiana University School of Medicine
20
Characterization of two distinct structural classes of selective aldehyde dehydrogenase 1A1 inhibitors.EBI
Indiana University
22
Development of selective inhibitors for aldehyde dehydrogenases based on substituted indole-2,3-diones.EBI
Indiana University School of Medicine
42
Bis(dialkylaminethiocarbonyl)disulfides as potent and selective monoglyceride lipase inhibitors.EBI
Universite Catholique De Louvain
1
Structure of daidzin, a naturally occurring anti-alcohol-addiction agent, in complex with human mitochondrial aldehyde dehydrogenase.EBI
University of Oxford
4
 
Elgonica-Dimers A and B, Two Potent Alcohol Metabolism Inhibitory Constituents of Aloe arborescensEBI
TBA
2
Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia.EBI
University of Cambridge
5
Scaffold hopping based designing of selective ALDH1A1 inhibitors to overcome cyclophosphamide resistance: synthesis and biological evaluation.EBI
Punjabi University
22
Discovery and development of selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors.EBI
China Pharmaceutical University
9
Discovery of benzimidazole derivatives as potent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with glucose consumption improving activity.EBI
China Pharmaceutical University
1
Magnolol, a natural aldehyde dehydrogenase-2 agonist, inhibits the proliferation and collagen synthesis of cardiac fibroblasts.EBI
Southern Medical University
15
Development of new disulfiram analogues as ALDH1a1-selective inhibitors.EBI
Umm Al-Qura University
2
The discovery of novel small molecule allosteric activators of aldehyde dehydrogenase 2.EBI
Second Military Medical University
24
Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents.EBI
The Pennsylvania State University College of Medicine
42
Synthesis of potential antidipsotropic isoflavones: inhibitors of the mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway.EBI
Harvard Medical School
13
The mitochondrial monoamine oxidase-aldehyde dehydrogenase pathway: a potential site of action of daidzin.EBI
Harvard Medical School
2
Design, synthesis, and ex vivo evaluation of a selective inhibitor for retinaldehyde dehydrogenase enzymes.EBI
University of Oklahoma Health Sciences Center
32
Structure-Based Optimization of a Novel Class of Aldehyde Dehydrogenase 1A (ALDH1A) Subfamily-Selective Inhibitors as Potential Adjuncts to Ovarian Cancer Chemotherapy.EBI
Indiana University School of Medicine
107
Discovery of Orally Bioavailable, Quinoline-Based Aldehyde Dehydrogenase 1A1 (ALDH1A1) Inhibitors with Potent Cellular Activity.EBI
National Center For Advancing Translational Sciences
4
PROTEIN TYROSINE PHOSPHATASE INHIBITORS AND USES THEREOFBDB
Nerio Therapeutics
20
ROR-GAMMA MODULATORSBDB
Escalier Biosciences
37
Substituted indazole derivatives active as kinase inhibitiorsBDB
Nerviano Medical Sciences
2
New IDH1 mutant inhibitors for treatment of acute myeloid leukemiaBDB
Albert Einstein College of Medicine
103
Aminomethyl-4-imidazolesBDB
Hoffmann-La Roche
3
Development and biological evaluation of a novel aurora A kinase inhibitor.BDB
Parc De Recerca Biomedica De Barcelona